APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mucopolysaccharidosis II

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mucopolysaccharidosis II Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchMucopolysaccharidosis II Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Mucopolysaccharidosis II Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Mucopolysaccharidosis II Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mucopolysaccharidosis II Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mucopolysaccharidosis II Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Mucopolysaccharidosis II market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mucopolysaccharidosis II is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mucopolysaccharidosis II is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mucopolysaccharidosis II is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mucopolysaccharidosis II is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mucopolysaccharidosis II include Takeda, Sangamo BioSciences, Inc., RegenxBio Inc., Laboratorios Del Dr. Esteve S.A., JCR Pharmaceuticals Co., Ltd., Inventiva, Green Cross Corporation, Bioasis Technologies Inc. and ArmaGen Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mucopolysaccharidosis II market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mucopolysaccharidosis II and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mucopolysaccharidosis II sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mucopolysaccharidosis II market size, projected growth trends, production technologies, key applications, and end-use industries.

Mucopolysaccharidosis II Segment by Company

Takeda

Sangamo BioSciences, Inc.

RegenxBio Inc.

Laboratorios Del Dr. Esteve S.A.

JCR Pharmaceuticals Co., Ltd.

Inventiva

Green Cross Corporation

Bioasis Technologies Inc.

ArmaGen Inc.

AngioChem Inc.

Alexion Pharmaceuticals, Inc.

Mucopolysaccharidosis II Segment by Type

AGT-182

DUOC-01

EGT-301

JR-032

JR-141

Others

Mucopolysaccharidosis II Segment by Application

Clinic

Hospital

Research Center

Others

Mucopolysaccharidosis II Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mucopolysaccharidosis II market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mucopolysaccharidosis II and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mucopolysaccharidosis II.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mucopolysaccharidosis II market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mucopolysaccharidosis II manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mucopolysaccharidosis II in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mucopolysaccharidosis II in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mucopolysaccharidosis II Industry Trends Table 2. Mucopolysaccharidosis II Industry Drivers Table 3. Mucopolysaccharidosis II Industry Opportunities and Challenges Table 4. Mucopolysaccharidosis II Industry Restraints Table 5. Global Mucopolysaccharidosis II Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mucopolysaccharidosis II Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mucopolysaccharidosis II Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Mucopolysaccharidosis II Sales Market Share by Manufacturers Table 9. Global Mucopolysaccharidosis II Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Mucopolysaccharidosis II Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mucopolysaccharidosis II Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mucopolysaccharidosis II Manufacturers, Product Type & Application Table 13. Global Mucopolysaccharidosis II Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mucopolysaccharidosis II by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AGT-182 Table 17. Major Manufacturers of DUOC-01 Table 18. Major Manufacturers of EGT-301 Table 19. Major Manufacturers of JR-032 Table 20. Major Manufacturers of JR-141 Table 21. Major Manufacturers of Others Table 22. Global Mucopolysaccharidosis II Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 24. Global Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 25. Global Mucopolysaccharidosis II Sales Market Share by Type (2021-2026) Table 26. Global Mucopolysaccharidosis II Sales Market Share by Type (2027-2032) Table 27. Global Mucopolysaccharidosis II Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 28. Global Mucopolysaccharidosis II Revenue by Type (2021-2026) & (W Units) Table 29. Global Mucopolysaccharidosis II Revenue by Type (2027-2032) & (W Units) Table 30. Global Mucopolysaccharidosis II Revenue Market Share by Type (2021-2026) Table 31. Global Mucopolysaccharidosis II Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Hospital Table 34. Major Manufacturers of Research Center Table 35. Major Manufacturers of Others Table 36. Global Mucopolysaccharidosis II Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 38. Global Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 39. Global Mucopolysaccharidosis II Sales Market Share by Application (2021-2026) Table 40. Global Mucopolysaccharidosis II Sales Market Share by Application (2027-2032) Table 41. Global Mucopolysaccharidosis II Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Mucopolysaccharidosis II Revenue by Application (2021-2026) & (W Units) Table 43. Global Mucopolysaccharidosis II Revenue by Application (2027-2032) & (W Units) Table 44. Global Mucopolysaccharidosis II Revenue Market Share by Application (2021-2026) Table 45. Global Mucopolysaccharidosis II Revenue Market Share by Application (2027-2032) Table 46. Global Mucopolysaccharidosis II Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Mucopolysaccharidosis II Sales by Region (2021-2026) & (W Units) Table 48. Global Mucopolysaccharidosis II Sales Market Share by Region (2021-2026) Table 49. Global Mucopolysaccharidosis II Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Mucopolysaccharidosis II Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 53. North America Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 54. Europe Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 56. Europe Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 63. Global Mucopolysaccharidosis II Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Mucopolysaccharidosis II Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Mucopolysaccharidosis II Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Mucopolysaccharidosis II Revenue Market Share by Region (2021-2026) Table 67. Global Mucopolysaccharidosis II Revenue Market Share by Region (2027-2032) Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Mucopolysaccharidosis II Product Portfolio Table 72. Takeda Recent Development Table 73. Sangamo BioSciences, Inc. Company Information Table 74. Sangamo BioSciences, Inc. Business Overview Table 75. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio Table 77. Sangamo BioSciences, Inc. Recent Development Table 78. RegenxBio Inc. Company Information Table 79. RegenxBio Inc. Business Overview Table 80. RegenxBio Inc. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio Table 82. RegenxBio Inc. Recent Development Table 83. Laboratorios Del Dr. Esteve S.A. Company Information Table 84. Laboratorios Del Dr. Esteve S.A. Business Overview Table 85. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio Table 87. Laboratorios Del Dr. Esteve S.A. Recent Development Table 88. JCR Pharmaceuticals Co., Ltd. Company Information Table 89. JCR Pharmaceuticals Co., Ltd. Business Overview Table 90. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio Table 92. JCR Pharmaceuticals Co., Ltd. Recent Development Table 93. Inventiva Company Information Table 94. Inventiva Business Overview Table 95. Inventiva Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Inventiva Mucopolysaccharidosis II Product Portfolio Table 97. Inventiva Recent Development Table 98. Green Cross Corporation Company Information Table 99. Green Cross Corporation Business Overview Table 100. Green Cross Corporation Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Green Cross Corporation Mucopolysaccharidosis II Product Portfolio Table 102. Green Cross Corporation Recent Development Table 103. Bioasis Technologies Inc. Company Information Table 104. Bioasis Technologies Inc. Business Overview Table 105. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio Table 107. Bioasis Technologies Inc. Recent Development Table 108. ArmaGen Inc. Company Information Table 109. ArmaGen Inc. Business Overview Table 110. ArmaGen Inc. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio Table 112. ArmaGen Inc. Recent Development Table 113. AngioChem Inc. Company Information Table 114. AngioChem Inc. Business Overview Table 115. AngioChem Inc. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. AngioChem Inc. Mucopolysaccharidosis II Product Portfolio Table 117. AngioChem Inc. Recent Development Table 118. Alexion Pharmaceuticals, Inc. Company Information Table 119. Alexion Pharmaceuticals, Inc. Business Overview Table 120. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio Table 122. Alexion Pharmaceuticals, Inc. Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Mucopolysaccharidosis II Distributors List Table 126. Mucopolysaccharidosis II Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Mucopolysaccharidosis II Product Image Figure 2. Global Mucopolysaccharidosis II Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mucopolysaccharidosis II Market Size (2021-2032) & (US$ Million) Figure 4. Global Mucopolysaccharidosis II Sales (2021-2032) & (W Units) Figure 5. Global Mucopolysaccharidosis II Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mucopolysaccharidosis II Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AGT-182 Image Figure 9. DUOC-01 Image Figure 10. EGT-301 Image Figure 11. JR-032 Image Figure 12. JR-141 Image Figure 13. Others Image Figure 14. Global Mucopolysaccharidosis II Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Mucopolysaccharidosis II Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Mucopolysaccharidosis II Sales Market Share by Type (2021-2032) Figure 17. Global Mucopolysaccharidosis II Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 18. Global Mucopolysaccharidosis II Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Mucopolysaccharidosis II Revenue Market Share by Type (2021-2032) Figure 20. Clinic Image Figure 21. Hospital Image Figure 22. Research Center Image Figure 23. Others Image Figure 24. Global Mucopolysaccharidosis II Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Mucopolysaccharidosis II Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Mucopolysaccharidosis II Sales Market Share by Application (2021-2032) Figure 27. Global Mucopolysaccharidosis II Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Mucopolysaccharidosis II Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Mucopolysaccharidosis II Revenue Market Share by Application (2021-2032) Figure 30. North America Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Mucopolysaccharidosis II Sales Market Share by Country (2021-2032) Figure 32. U.S. Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Mucopolysaccharidosis II Sales Market Share by Country (2021-2032) Figure 37. Germany Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Mucopolysaccharidosis II Sales Market Share by Country (2021-2032) Figure 44. China Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Mucopolysaccharidosis II Sales Market Share by Country (2021-2032) Figure 52. Brazil Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Mucopolysaccharidosis II Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Mucopolysaccharidosis II Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Mucopolysaccharidosis II Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Figure 63. North America Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Figure 65. Europe Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Mucopolysaccharidosis II Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Mucopolysaccharidosis II Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • AGT-182
  • DUOC-01
  • EGT-301
  • JR-032
  • JR-141
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
  • Others
Companies covered
  • Takeda
  • Sangamo BioSciences, Inc.
  • RegenxBio Inc.
  • Laboratorios Del Dr. Esteve S.A.
  • JCR Pharmaceuticals Co., Ltd.
  • Inventiva
  • Green Cross Corporation
  • Bioasis Technologies Inc.
  • ArmaGen Inc.
  • AngioChem Inc.
  • Alexion Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mucopolysaccharidosis II Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mucopolysaccharidosis II Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mucopolysaccharidosis II Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mucopolysaccharidosis II Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mucopolysaccharidosis II Market Dynamics
  1. 2.1 Mucopolysaccharidosis II Industry Trends
  2. 2.2 Mucopolysaccharidosis II Industry Drivers
  3. 2.3 Mucopolysaccharidosis II Industry Opportunities and Challenges
  4. 2.4 Mucopolysaccharidosis II Industry Restraints
3 Mucopolysaccharidosis II Market by Manufacturers
  1. 3.1 Global Mucopolysaccharidosis II Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mucopolysaccharidosis II Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mucopolysaccharidosis II Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mucopolysaccharidosis II Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mucopolysaccharidosis II Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mucopolysaccharidosis II Manufacturers, Product Type & Application
  7. 3.7 Global Mucopolysaccharidosis II Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mucopolysaccharidosis II Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mucopolysaccharidosis II Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mucopolysaccharidosis II Tier 1, Tier 2, and Tier 3
4 Mucopolysaccharidosis II Market by Type
  1. 4.1 Mucopolysaccharidosis II Type Introduction
  2. 4.1.1 AGT-182
  3. 4.1.2 DUOC-01
  4. 4.1.3 EGT-301
  5. 4.1.4 JR-032
  6. 4.1.5 JR-141
  7. 4.1.6 Others
  8. 4.2 Global Mucopolysaccharidosis II Sales by Type
  9. 4.2.1 Global Mucopolysaccharidosis II Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Mucopolysaccharidosis II Sales by Type (2021-2032)
  11. 4.2.3 Global Mucopolysaccharidosis II Sales Market Share by Type (2021-2032)
  12. 4.3 Global Mucopolysaccharidosis II Revenue by Type
  13. 4.3.1 Global Mucopolysaccharidosis II Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Mucopolysaccharidosis II Revenue by Type (2021-2032)
  15. 4.3.3 Global Mucopolysaccharidosis II Revenue Market Share by Type (2021-2032)
5 Mucopolysaccharidosis II Market by Application
  1. 5.1 Mucopolysaccharidosis II Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Research Center
  5. 5.1.4 Others
  6. 5.2 Global Mucopolysaccharidosis II Sales by Application
  7. 5.2.1 Global Mucopolysaccharidosis II Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Mucopolysaccharidosis II Sales by Application (2021-2032)
  9. 5.2.3 Global Mucopolysaccharidosis II Sales Market Share by Application (2021-2032)
  10. 5.3 Global Mucopolysaccharidosis II Revenue by Application
  11. 5.3.1 Global Mucopolysaccharidosis II Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Mucopolysaccharidosis II Revenue by Application (2021-2032)
  13. 5.3.3 Global Mucopolysaccharidosis II Revenue Market Share by Application (2021-2032)
6 Global Mucopolysaccharidosis II Sales by Region
  1. 6.1 Global Mucopolysaccharidosis II Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mucopolysaccharidosis II Sales by Region (2021-2032)
  3. 6.2.1 Global Mucopolysaccharidosis II Sales by Region (2021-2026)
  4. 6.2.2 Global Mucopolysaccharidosis II Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mucopolysaccharidosis II Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mucopolysaccharidosis II Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mucopolysaccharidosis II Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mucopolysaccharidosis II Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mucopolysaccharidosis II Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mucopolysaccharidosis II Revenue by Region
  1. 7.1 Global Mucopolysaccharidosis II Revenue by Region
  2. 7.1.1 Global Mucopolysaccharidosis II Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mucopolysaccharidosis II Revenue by Region (2021-2026)
  4. 7.1.3 Global Mucopolysaccharidosis II Revenue by Region (2027-2032)
  5. 7.1.4 Global Mucopolysaccharidosis II Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mucopolysaccharidosis II Revenue (2021-2032)
  8. 7.2.2 North America Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mucopolysaccharidosis II Revenue (2021-2032)
  11. 7.3.2 Europe Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mucopolysaccharidosis II Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mucopolysaccharidosis II Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mucopolysaccharidosis II Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Mucopolysaccharidosis II Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Sangamo BioSciences, Inc.
  8. 8.2.1 Sangamo BioSciences, Inc. Company Information
  9. 8.2.2 Sangamo BioSciences, Inc. Business Overview
  10. 8.2.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio
  12. 8.2.5 Sangamo BioSciences, Inc. Recent Developments
  13. 8.3 RegenxBio Inc.
  14. 8.3.1 RegenxBio Inc. Company Information
  15. 8.3.2 RegenxBio Inc. Business Overview
  16. 8.3.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio
  18. 8.3.5 RegenxBio Inc. Recent Developments
  19. 8.4 Laboratorios Del Dr. Esteve S.A.
  20. 8.4.1 Laboratorios Del Dr. Esteve S.A. Company Information
  21. 8.4.2 Laboratorios Del Dr. Esteve S.A. Business Overview
  22. 8.4.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio
  24. 8.4.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
  25. 8.5 JCR Pharmaceuticals Co., Ltd.
  26. 8.5.1 JCR Pharmaceuticals Co., Ltd. Company Information
  27. 8.5.2 JCR Pharmaceuticals Co., Ltd. Business Overview
  28. 8.5.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio
  30. 8.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
  31. 8.6 Inventiva
  32. 8.6.1 Inventiva Company Information
  33. 8.6.2 Inventiva Business Overview
  34. 8.6.3 Inventiva Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Inventiva Mucopolysaccharidosis II Product Portfolio
  36. 8.6.5 Inventiva Recent Developments
  37. 8.7 Green Cross Corporation
  38. 8.7.1 Green Cross Corporation Company Information
  39. 8.7.2 Green Cross Corporation Business Overview
  40. 8.7.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Green Cross Corporation Mucopolysaccharidosis II Product Portfolio
  42. 8.7.5 Green Cross Corporation Recent Developments
  43. 8.8 Bioasis Technologies Inc.
  44. 8.8.1 Bioasis Technologies Inc. Company Information
  45. 8.8.2 Bioasis Technologies Inc. Business Overview
  46. 8.8.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio
  48. 8.8.5 Bioasis Technologies Inc. Recent Developments
  49. 8.9 ArmaGen Inc.
  50. 8.9.1 ArmaGen Inc. Company Information
  51. 8.9.2 ArmaGen Inc. Business Overview
  52. 8.9.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio
  54. 8.9.5 ArmaGen Inc. Recent Developments
  55. 8.10 AngioChem Inc.
  56. 8.10.1 AngioChem Inc. Company Information
  57. 8.10.2 AngioChem Inc. Business Overview
  58. 8.10.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AngioChem Inc. Mucopolysaccharidosis II Product Portfolio
  60. 8.10.5 AngioChem Inc. Recent Developments
  61. 8.11 Alexion Pharmaceuticals, Inc.
  62. 8.11.1 Alexion Pharmaceuticals, Inc. Company Information
  63. 8.11.2 Alexion Pharmaceuticals, Inc. Business Overview
  64. 8.11.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio
  66. 8.11.5 Alexion Pharmaceuticals, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mucopolysaccharidosis II Value Chain Analysis
  2. 9.1.1 Mucopolysaccharidosis II Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mucopolysaccharidosis II Production Mode & Process
  6. 9.2 Mucopolysaccharidosis II Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mucopolysaccharidosis II Distributors
  9. 9.2.3 Mucopolysaccharidosis II Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst